with false information on the label, including cases where the compounding pharmacies named on the labels did not exist or where licensed pharmacies named on the labels had not made the products
This is not a supplement filling a theoretical gap
The off period allows assessment of sustained metabolic benefits after discontinuation
For instance, a patients follow-up visit for B12 re-evaluation is not recorded, causing issues with continuity of care
Final action: After consideration of public comments, we are finalizing that the effective date of the revisions at 180.50, including removal of the estimated allowed amount, disclosure of the median, and 10th and 90th percentile, allowed amounts and the count of allowed amounts, the attestation requirement, and the NPIs, will be January 1, 2026
M., Reddy, V., & Pillarisetty, L